COMMUNIQUÉS West-GlobeNewswire

Coloplast awarded general urological products agreement with Premier Inc.
25/02/2019
Coloplast, a global medical device company and leader in intimate healthcare needs, has been awarded a three-year group purchasing agreement for general urological products with Premier. The new agreement allows Premier [...]
Medtronic Wraps Up Scientific Data Presentations at the Advanced Technologies and Treatments for Diabetes International Conference
25/02/2019
DUBLIN - February 25, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced a successful conclusion to the 12th International Conference on Advanced Technologies & Treatments for [...]
4 Companies Shaping the Cannabis Retail Market
25/02/2019
VANCOUVER, British Columbia, Feb. 25, 2019 (GLOBE NEWSWIRE) -- The cannabis retail market remains one of marijuana's biggest unknowns. Companies have been working on different approaches when it comes to developing [...]
Ventura Cannabis and Wellness Corp. Provides Share Consolidation Update, Announces Conference Call
25/02/2019
Not for distribution to United States newswire services or for dissemination in the United States. LOS ANGELES, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Ventura Cannabis and Wellness Corp. (" VCAN " or the " Company ") (CSE: [...]
OrthoPediatrics Corp. Announces Global Launch of New BandLoc DUO
25/02/2019
WARSAW, Ind., Feb. 25, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the launch [...]
FemPulse Announces Enrollment in Multi-Center EVANESCE-OAB Study
25/02/2019
Study of innovative bioelectronic medicine therapy for treatment of overactive bladder in women MINNEAPOLIS, Feb. 25, 2019 (GLOBE NEWSWIRE) -- FemPulse Corporation (FemPulse), a private, clinical-stage bioelectronic [...]
Alphatec Announces FDA Clearance of its Automated SafeOp Neuromonitoring System to Address Significant Unmet Needs in Spine Surgery
25/02/2019
CARLSBAD, Calif., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC) announced today that it has received 510(k) clearance from the U.S. Food & Drug Administration ( [...]
ABclonal Technology Partners with BenchSci to Boost Discoverability of its Novel Products
25/02/2019
Partnership will leverage BenchSci’s AI to help scientists find the right reagents and enable ABclonal to compete on product quality BOSTON, Feb. 25, 2019 (GLOBE NEWSWIRE) -- ABclonal Technology, a new and growing [...]
Venerate CG label registered for use in California
25/02/2019
DAVIS, Calif., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ:MBII) (MBI), a leading developer of biological crop protection and plant health solutions, today announced that Venerate ® CG has [...]
Novo Nordisk A/S - Share repurchase programme
25/02/2019
Bagsværd, Denmark, 25 February 2019 - On 1 February 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]
OpGen Appoints R. Don Elsey to Board of Directors
25/02/2019
GAITHERSBURG, Md., Feb. 25, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) announces the appointment R. Don Elsey to the company’s board of directors and audit committee, effective February 21, 2019. He will serve [...]
Eyenovia Announces Confirmatory Results from Second MicroStat Phase III Registration Study for Mydriasis
25/02/2019
MIST-2 study meets primary endpoint First-in-class fixed combination mydriatic agent demonstrated robust efficacy, good tolerability in confirmatory MIST-2 Study NEW YORK, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc [...]
Establishment Labs to Announce Fourth Quarter and Full Year 2018 Financial Results
25/02/2019
NEW YORK, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics [...]
Assure Holdings Receives DTC Eligibility and Approval for Uplisting to OTCQB
25/02/2019
DENVER, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has received approval from the Depository [...]
Hemostemix Announces UC Davis Health Added as a Trial Site for Phase II Clinical Trial
25/02/2019
CALGARY, Alberta, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM; OTCQB:HMTXF) is pleased to announce that it has received all approvals from UC Davis Health (“UC [...]
Advantis Corp Announces Imminent Lease Signing for OC Location, a Tripling of Monthly Amster-Can Orders with Existing Client
25/02/2019
NEWPORT BEACH, CA, Feb. 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) CEO, Darren Cherry, announced that he plans on signing the lease agreement for the Orange County packaging [...]
Chembio Diagnostics to Report Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019
25/02/2019
MEDFORD, N.Y., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial [...]
Melinta Therapeutics Announces Closing of Initial $75 Million Vatera Convertible Loan Funding
25/02/2019
– Amendment to Deerfield Facility Agreement Becomes Effective – – John H. Johnson Appointed Permanent Chief Executive Officer – – Company to Report Fourth Quarter and Full Year 2018 Financial Results on March 13, 2019 [...]
Prominent Cardiovascular Expert, James J. Ferguson, M.D., FACC, FAHA Joins Matinas BioPharma as Chief Medical Officer
25/02/2019
- Former Head of U.S. Cardiovascular Medical Affairs at Amgen and Global Cardiovascular Medical Affairs at AstraZeneca to lead clinical development of MAT9001, a potential best-in-class prescription-only omega-3 drug [...]

Pages